VPS45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.400210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.430800E-01
Normal-vs-Stage2
1.111760E-01
Normal-vs-Stage3
1.345430E-01
Normal-vs-Stage4
5.685000E-01
Stage1-vs-Stage2
2.291800E-01
Stage1-vs-Stage3
1.766170E-01
Stage1-vs-Stage4
9.839600E-01
Stage2-vs-Stage3
1.893030E-01
Stage2-vs-Stage4
3.086400E-01
Stage3-vs-Stage4
2.357200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.410950E-01
Normal-vs-AfricanAmerican
4.265200E-01
Normal-vs-Asian
1.424750E-01
Caucasian-vs-AfricanAmerican
3.475600E-01
Caucasian-vs-Asian
7.301400E-01
AfricanAmerican-vs-Asian
5.016200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.704980E-01
Normal-vs-Female
1.189040E-01
Male-vs-Female
6.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.540100E-02
Normal-vs-Age(41-60Yrs)
5.055800E-02
Normal-vs-Age(61-80Yrs)
1.823620E-01
Normal-vs-Age(81-100Yrs)
2.764600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.536200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.772200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.131600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.076400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.939800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.220800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.054200E-02
Normal-vs-Daily Drinker
7.759700E-02
Normal-vs-Weekly Drinker
1.807000E-01
Normal-vs-Occasional Drinker
3.632800E-01
Normal-vs-Social Drinker
2.277800E-01
Non Drinker-vs-Daily Drinker
8.989600E-01
Non Drinker-vs-Weekly Drinker
2.687200E-01
Non Drinker-vs-Occasional Drinker
2.545800E-02
Non Drinker-vs-Social Drinker
1.369760E-01
Daily Drinker-vs-Weekly Drinker
2.699400E-01
Daily Drinker-vs-Occasional Drinker
3.328100E-02
Daily Drinker-vs-Social Drinker
1.470040E-01
Weekly Drinker-vs-Occasional Drinker
3.511000E-01
Weekly Drinker-vs-Social Drinker
7.508200E-01
Occasional Drinker-vs-Social Drinker
5.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.994390E-01
Normal-vs-Grade 2
5.644200E-01
Normal-vs-Grade 3
5.639000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.233000E-01
Grade 1-vs-Grade 3
6.191000E-01
Grade 1-vs-Grade 4
1.994390E-01
Grade 2-vs-Grade 3
9.719400E-01
Grade 2-vs-Grade 4
5.644200E-01
Grade 3-vs-Grade 4
5.639000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.308400E-02
Normal-vs-NonDiabetic
1.577180E-01
Diabetic-vs-NonDiabetic
6.438200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.722970E-01
Normal-vs-NoPancreatitis
1.251760E-01
Pancreatitis-vs-NoPancreatitis
5.534200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.364800E-01
Normal-vs-N1
9.410300E-02
N0-vs-N1
2.006400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.365000E-01
Normal-vs-TP53-NonMutant
3.669000E-01
TP53-Mutant-vs-TP53-NonMutant
9.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
